Cambridge Healthtech Institute’s 11th Annual
Advances in Immunotherapy
Supercharging the Immune System
May 12-13, 2026
Cambridge Healthtech Institute’s 11th annual Advances in Immunotherapy conference explores the most recent breakthroughs shaping the future of immunotherapy for oncology and autoimmune disease. Key topics include: overcoming resistance, targeting the TME, harnessing the microbiome to improve outcomes, dual-targeting CAR Ts, engineering safer and more effective cell therapies, and advancing rational combination approaches. Examples will come from the worlds of biotherapeutics, proteins, cell-based therapies, and more.
Coverage will include, but is not limited to:
Overcoming Resistance and Limitations in Immunotherapy
- Latest advances in overcoming tumor microenvironment
- Overcoming resistance and evasion
- Next-generation checkpoints—targeting combination checkpoint pathways
- Advances in immunocytokines
- Impact of microbiome on immunotherapies
Engineering Safer, More Efficacious Cell Therapies
- Dual Targeting Cell Therapies
- Armored CAR Ts—reshape the tumor microenvironment and sustain T cell function
- Novel CAR designs, gene-edited/base-edited CARs
- Synthetic immune receptors
- Engineer CAR Ts that mimic native TCR synapse formation
- CAR T switches, logic gates to control function and safety
- Mitigating toxicity and resistance
Cell Therapies against Solid Tumors
- Latest engineering strategies to target solid tumors
- CAR T against solid tumors
- TCR Ts to target solid tumors
- Advances in CAR-NKs, RNA Cell Therapies, T Regs, Gamma deltas
- Genetically modified cell therapies
- Next-generation TILs—updates
Cell Therapies and Immunotherapies for Autoimmune and Fibrosis
- Latest immunotherapy and cell therapy strategies to target autoimmune disease
- CAR T for autoimmune—updates from major players: Cartesian, Cabaletta Bio
- Agonists against autoimmune disease
- Next-generation autoimmune therapies
The deadline for priority consideration is October 31, 2025.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation: